FR2081532B1 - - Google Patents

Info

Publication number
FR2081532B1
FR2081532B1 FR7105916A FR7105916A FR2081532B1 FR 2081532 B1 FR2081532 B1 FR 2081532B1 FR 7105916 A FR7105916 A FR 7105916A FR 7105916 A FR7105916 A FR 7105916A FR 2081532 B1 FR2081532 B1 FR 2081532B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7105916A
Other versions
FR2081532A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Serono SpA
Original Assignee
Istituto Farmacologico Serono SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto Farmacologico Serono SpA filed Critical Istituto Farmacologico Serono SpA
Publication of FR2081532A1 publication Critical patent/FR2081532A1/fr
Application granted granted Critical
Publication of FR2081532B1 publication Critical patent/FR2081532B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FR7105916A 1970-02-21 1971-02-22 Expired FR2081532B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2094670A IT1033040B (it) 1970-02-21 1970-02-21 4 5 difenilossazoli 2 amminometil e 2,2 amminoetil sostituiti

Publications (2)

Publication Number Publication Date
FR2081532A1 FR2081532A1 (fr) 1971-12-03
FR2081532B1 true FR2081532B1 (fr) 1974-04-12

Family

ID=11174442

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7105916A Expired FR2081532B1 (fr) 1970-02-21 1971-02-22

Country Status (6)

Country Link
JP (1) JPS504662B1 (fr)
CH (1) CH554360A (fr)
DE (1) DE2108437A1 (fr)
FR (1) FR2081532B1 (fr)
GB (1) GB1284379A (fr)
IT (1) IT1033040B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2012716A1 (fr) * 1989-03-22 1990-09-22 Akito Tanaka Composes de thiazole, procede de preparation et compose pharmaceutique les contenant
FR2677355B1 (fr) * 1991-06-06 1993-08-20 Bellon Labor Sa Roger Nouveaux derives de l'oxazole, leur preparation et les compositions pharmaceutiques qui les contiennent.
FR2677477B1 (fr) * 1991-06-06 1993-08-20 Bellon Labor Sa Roger Nouveaux derives de l'oxazole leur preparation, leur utilisation et les compositions pharmaceutiques qui les contiennent.
EP0582164B1 (fr) * 1992-07-31 1998-12-23 Bristol-Myers Squibb Company Dérivés de diphényl oxazoles, thiazoles et imidazoles comme inhibiteurs de la réabsorption d'adénosine
US6090825A (en) * 1994-11-23 2000-07-18 Glaxo Wellcome Inc. Oxazole derivatives as antagonists of alpha 1C andrenergic receptors
EP1064289A1 (fr) * 1998-03-18 2001-01-03 Ariad Pharmaceuticals, Inc. Inhibiteurs de transduction de signaux heterocycliques et compositions les contenant
FR2894578B1 (fr) * 2005-12-12 2008-02-01 Sanofi Aventis Sa Derives heterocycliques, leur preparation et leur application en therapeutique.
EP3162798B1 (fr) * 2007-09-28 2021-04-14 Takeda Pharmaceutical Company Limited Nouveaux composés hétérocycliques à 5 chaînons

Also Published As

Publication number Publication date
GB1284379A (en) 1972-08-09
JPS504662B1 (fr) 1975-02-22
FR2081532A1 (fr) 1971-12-03
IT1033040B (it) 1979-07-10
DE2108437A1 (de) 1971-11-11
CH554360A (it) 1974-09-30

Similar Documents

Publication Publication Date Title
AR204384A1 (fr)
FR2081532B1 (fr)
ATA96471A (fr)
AU2044470A (fr)
AU1473870A (fr)
AU1146470A (fr)
AU1517670A (fr)
AU1716970A (fr)
AU1833270A (fr)
AU2085370A (fr)
AU2017870A (fr)
AR195465A1 (fr)
AU2144270A (fr)
AU1832970A (fr)
AU1974970A (fr)
AU1969370A (fr)
AU1083170A (fr)
ATA672271A (fr)
AU2119370A (fr)
AU1581370A (fr)
AU1943370A (fr)
AU1918570A (fr)
AU2130770A (fr)
AU2131570A (fr)
AU1881070A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse